Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anti-human IL-26 monoclonal antibody
- Development stage
- Preclinical
- Lead developer
- Y's AC
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous, Intraperitoneal
01
Overview
Y's AC is developing a monoclonal antibody targeting Interleukin-26 (IL-26), a member of the IL-10 cytokine family. IL-26 is a pro-inflammatory cytokine that is often upregulated in chronic inflammatory diseases and certain malignancies. By binding to and neutralizing IL-26, this therapeutic candidate aims to mitigate inflammation and fibrosis in conditions such as chronic obstructive pulmonary disease (COPD), lung fibrosis, liver sclerosis, and scleroderma. Furthermore, the antibody has demonstrated potential in inhibiting tumor cell proliferation and metastasis, suggesting its utility as an antineoplastic agent. The project is currently in the preclinical stage of development.
- Other names
- anti-IL-26 monoclonal antibodyanti-IL26 monoclonal antibodyanti-IL 26 monoclonal antibodyanti-IL-26 mAbanti-IL26 mAbanti-IL 26 mAb
02
Targets
IL26 (Interleukin-26)
Beyond the preview
Go deeper on anti-human IL-26 monoclonal antibody.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anti-human IL-26 monoclonal antibody.